tiprankstipranks
Emergent BioSolutions upgraded to Buy at Benchmark after ‘upbeat’ Q4 report
PremiumThe FlyEmergent BioSolutions upgraded to Buy at Benchmark after ‘upbeat’ Q4 report
2M ago
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
PremiumThe Fly
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
2M ago
Emergent BioSolutions sees Q1 revenue $200M-$250M, consensus $185.4M
PremiumThe Fly
Emergent BioSolutions sees Q1 revenue $200M-$250M, consensus $185.4M
2M ago
Emergent BioSolutions options imply 36.4% move in share price post-earnings
PremiumThe FlyEmergent BioSolutions options imply 36.4% move in share price post-earnings
2M ago
Emergent BioSolutions options imply 25.1% move in share price post-earnings
PremiumThe Fly
Emergent BioSolutions options imply 25.1% move in share price post-earnings
2M ago
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
PremiumPress Releases
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
2M ago
EBS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsEBS Upcoming Earnings Report: What to Expect?
2M ago
Emergent extending shelf-life of newly manufactured NARCAN, FDA says
PremiumThe Fly
Emergent extending shelf-life of newly manufactured NARCAN, FDA says
3M ago
Emergent BioSolutions awarded procurement contract valued up to $235.8M
PremiumThe Fly
Emergent BioSolutions awarded procurement contract valued up to $235.8M
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100